参考文章(64)
T. Tanizawa, R. Kamiyama, M. Kitagawa, S. Yoshida, T. Kuwata, p53 expression in myeloid cells of myelodysplastic syndromes. Association with evolution of overt leukemia. American Journal of Pathology. ,vol. 145, pp. 338- 344 ,(1994)
Thomas A, El Rouby S, Krajewski S, Reed Jc, Newcomb Ew, Potmesil M, Silber R, Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance. Oncogene. ,vol. 12, pp. 1055- 1062 ,(1996)
K Sugimoto, N Hirano, H Toyoshima, S Chiba, H Mano, F Takaku, Y Yazaki, H Hirai, Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia. Blood. ,vol. 81, pp. 3022- 3026 ,(1993) , 10.1182/BLOOD.V81.11.3022.3022
A Bedi, BA Zehnbauer, JP Barber, SJ Sharkis, RJ Jones, Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia Blood. ,vol. 83, pp. 2038- 2044 ,(1994) , 10.1182/BLOOD.V83.8.2038.2038
KM Debatin, CK Goldman, TA Waldmann, PH Krammer, APO-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia. Blood. ,vol. 81, pp. 2972- 2977 ,(1993) , 10.1182/BLOOD.V81.11.2972.2972
E Wattel, C Preudhomme, B Hecquet, M Vanrumbeke, B Quesnel, I Dervite, P Morel, P Fenaux, p53 Mutations Are Associated With Resistance to Chemotherapy and Short Survival in Hematologic Malignancies Blood. ,vol. 84, pp. 3148- 3157 ,(1994) , 10.1182/BLOOD.V84.9.3148.3148
A Bedi, JP Barber, GC Bedi, WS el-Deiry, D Sidransky, MS Vala, AJ Akhtar, J Hilton, RJ Jones, BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents Blood. ,vol. 86, pp. 1148- 1158 ,(1995) , 10.1182/BLOOD.V86.3.1148.1148